RECENT PAT ANTI-CANC
| 中国学者近期发表的论文 | |
|---|---|
| 1. | Antisense technologies targeting fatty acid synthetic enzymes. Author: Lin J, Liu F, Jiang Y. Journal: Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):198-206. |
| 2. | Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential. Author: Luo DX, Tong DJ, Rajput S, Wang C, Liao DF, Cao D, Maser E. Journal: Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):168-84. |
| 3. | ATP citrate lyase inhibitors as novel cancer therapeutic agents. Author: Zu XY, Zhang QH, Liu JH, Cao RX, Zhong J, Yi GH, Quan ZH, Pizzorno G. Journal: Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):154-67. |
| 4. | An updated patent therapeutic agents targeting MMPs. Author: Shi ZG, Li JP, Shi LL, Li X. Journal: Recent Pat Anticancer Drug Discov. 2012 Jan;7(1):74-101. |
| 5. | Mitochondrial biogenesis Inhibitors for Anticancer Therapy: A Review of Recent Patents. Author: Wang J, Wen X, Liu J, Sun H. Journal: Recent Pat Anticancer Drug Discov. 2016 Apr 18. [Epub ahead of print] |
| 6. | Application of nanotechnology in the diagnosis and therapy of hepatocellular carcinoma. Author: Hou XY, Jiang G, Yang CS, Tang JQ, Wei ZP, Liu YQ. Journal: Recent Pat Anticancer Drug Discov. 2016 Mar 9. [Epub ahead of print] |
| 7. | Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells. Author: Wang Y, Ma J, Yan X, Chen X, Si L, Liu Y, Han J, Hao W, Zheng Q. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):215-27. |
| 8. | Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy. Author: Fang XN, Fu LW. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):141-51. |
| 9. | Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment. Author: Huang L, He R, Luo W, Zhu YS, Li J, Tan T, Zhang X, Hu Z, Luo D. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):184-96. |
| 10. | Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process. Author: Zhang K, Yang G, Wu W, Zhang J, Xia X, Jiang T, Cao J, Huang K, Qiu Z, Huang C. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):236-44. |